Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3957 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Dendreon boosted by Provenge trial success

Results from Dendreon’s pivotal phase III study (D9901) of Provenge (sipuleucel-T) were published in the Journal of Clinical Oncology. The double-blind, placebo-controlled study showed that the group of

FDA approves Genentech’s Lucentis

Lucentis was specifically developed for intraocular use in the eye to treat the underlying cause of ‘wet’ age-related macular degeneration (AMD) by targeting the molecular pathway that controls